Helen Brough is a Consultant in Pediatric Allergy and Immunology at the Evelina Children’s Hospital, St. Thomas’ Hospital, Professor of Pediatric Allergy at King’s College London University, Founder and Director of Children’s Allergy Doctors.

Her professional roles include:

1. Medical Advisor for the Natasha Allergy Research Foundation and Health Advisory Board for Allergy UK
2. Chair of the scientific advisory committee for the Parent and Baby NIHR Programme Grant
3. Member of the expert scientific board member for the NIH-funded CoFAR4 program

Previous roles include:

1. President of the Royal Society of Medicine Allergy and Immunology Section (2022-2024)
2. Chair of the European Academy of Allergy and Clinical Immunology (EAACI) Pediatric Section (2019-2022)
3. Meeting Secretary for the BSACI annual congress (2015-2016)

She is a Principal Investigator for the Stopping Eczema and Allergy (SEAL) study assessing whether proactive skin care in young infants with dry skin or eczema prevents the development of food allergy, the Pronuts study evaluating selective nut eating in nut allergic children, and the Global Assessment of Psychology Services for Food Allergy (GAPS) study. She was a co-investigator on several peanut oral and patch immunotherapy trials. She co-authored the European guidelines for the management of atopic eczema, and the food allergy prevention studies Learning Early About Peanut (LEAP, LEAP-ON, LEAP-Trio) and Enquiring About Tolerance (EAT) study.

Helen studied Medicine at King’s College, Cambridge University followed by clinical training at the Royal Free & University College London Medical School. Helen completed Paediatric Allergy and Immunology Higher Specialist Training at Guy’s and St. Thomas’ Hospital, King’s College London and Great Ormond Street Hospital as the MADEL Clinical Lecturer in Paediatric Allergy. Helen completed an MSc in Allergy gaining a distinction at the University of Southampton and completed her PhD at King's College London.